CN117752741A - 一种治疗系统性红斑狼疮相关免疫性血小板减少症的益气养阴祛瘀复方中药 - Google Patents
一种治疗系统性红斑狼疮相关免疫性血小板减少症的益气养阴祛瘀复方中药 Download PDFInfo
- Publication number
- CN117752741A CN117752741A CN202311858476.4A CN202311858476A CN117752741A CN 117752741 A CN117752741 A CN 117752741A CN 202311858476 A CN202311858476 A CN 202311858476A CN 117752741 A CN117752741 A CN 117752741A
- Authority
- CN
- China
- Prior art keywords
- blood
- yin
- deficiency
- chinese medicine
- blood stasis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 45
- 208000028622 Immune thrombocytopenia Diseases 0.000 title claims abstract description 22
- 208000031981 Thrombocytopenic Idiopathic Purpura Diseases 0.000 title claims abstract description 22
- 201000003710 autoimmune thrombocytopenic purpura Diseases 0.000 title claims abstract description 22
- 201000003067 thrombocytopenia due to platelet alloimmunization Diseases 0.000 title claims abstract description 22
- 201000000596 systemic lupus erythematosus Diseases 0.000 title claims abstract description 19
- 150000001875 compounds Chemical class 0.000 title claims abstract description 17
- 210000004369 blood Anatomy 0.000 claims abstract description 110
- 239000008280 blood Substances 0.000 claims abstract description 110
- 239000004480 active ingredient Substances 0.000 claims description 9
- 239000002994 raw material Substances 0.000 claims description 6
- 230000000694 effects Effects 0.000 abstract description 40
- 210000000952 spleen Anatomy 0.000 abstract description 35
- 230000007812 deficiency Effects 0.000 abstract description 34
- 210000003734 kidney Anatomy 0.000 abstract description 33
- 241001061264 Astragalus Species 0.000 abstract description 12
- 235000006533 astragalus Nutrition 0.000 abstract description 12
- 210000004233 talus Anatomy 0.000 abstract description 12
- 240000005373 Panax quinquefolius Species 0.000 abstract description 11
- 235000003140 Panax quinquefolius Nutrition 0.000 abstract description 11
- 229940079593 drug Drugs 0.000 abstract description 11
- 241000405911 Rehmannia glutinosa Species 0.000 abstract description 10
- 238000001816 cooling Methods 0.000 abstract description 10
- 208000031971 Yin Deficiency Diseases 0.000 abstract description 9
- 241000756042 Polygonatum Species 0.000 abstract description 8
- 244000042430 Rhodiola rosea Species 0.000 abstract description 7
- 235000003713 Rhodiola rosea Nutrition 0.000 abstract description 7
- 201000010099 disease Diseases 0.000 abstract description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 6
- 231100000765 toxin Toxicity 0.000 abstract description 6
- 239000003053 toxin Substances 0.000 abstract description 6
- 108700012359 toxins Proteins 0.000 abstract description 6
- 244000307697 Agrimonia eupatoria Species 0.000 abstract description 5
- 240000008564 Boehmeria nivea Species 0.000 abstract description 5
- 241000007126 Codonopsis pilosula Species 0.000 abstract description 5
- 241000830535 Ligustrum lucidum Species 0.000 abstract description 5
- 241000304195 Salvia miltiorrhiza Species 0.000 abstract description 5
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 abstract description 5
- 241000270666 Testudines Species 0.000 abstract description 5
- 235000000125 common agrimony Nutrition 0.000 abstract description 5
- 244000286838 Eclipta prostrata Species 0.000 abstract description 4
- 231100000614 poison Toxicity 0.000 abstract description 4
- 239000002574 poison Substances 0.000 abstract description 4
- 238000002360 preparation method Methods 0.000 abstract description 4
- 208000024891 symptom Diseases 0.000 abstract description 4
- 230000001225 therapeutic effect Effects 0.000 abstract description 4
- 235000002722 Dioscorea batatas Nutrition 0.000 abstract description 3
- 235000006536 Dioscorea esculenta Nutrition 0.000 abstract description 3
- 240000001811 Dioscorea oppositifolia Species 0.000 abstract description 3
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 abstract description 3
- 238000009825 accumulation Methods 0.000 abstract description 3
- 244000173853 Sanguisorba officinalis Species 0.000 abstract description 2
- 235000008282 Sanguisorba officinalis Nutrition 0.000 abstract description 2
- 229940126680 traditional chinese medicines Drugs 0.000 abstract 1
- 230000009466 transformation Effects 0.000 abstract 1
- 210000004185 liver Anatomy 0.000 description 22
- 230000000144 pharmacologic effect Effects 0.000 description 19
- 238000011160 research Methods 0.000 description 18
- 210000001772 blood platelet Anatomy 0.000 description 17
- 208000032843 Hemorrhage Diseases 0.000 description 16
- 230000003110 anti-inflammatory effect Effects 0.000 description 16
- 208000034158 bleeding Diseases 0.000 description 16
- 230000000740 bleeding effect Effects 0.000 description 16
- 210000004072 lung Anatomy 0.000 description 16
- 235000009508 confectionery Nutrition 0.000 description 15
- 230000017531 blood circulation Effects 0.000 description 13
- 238000011282 treatment Methods 0.000 description 13
- 150000004676 glycans Chemical class 0.000 description 11
- 229920001282 polysaccharide Polymers 0.000 description 11
- 239000005017 polysaccharide Substances 0.000 description 11
- 206010016256 fatigue Diseases 0.000 description 10
- 239000004615 ingredient Substances 0.000 description 10
- 206010025135 lupus erythematosus Diseases 0.000 description 10
- 210000002784 stomach Anatomy 0.000 description 10
- 241000699670 Mus sp. Species 0.000 description 9
- 206010037549 Purpura Diseases 0.000 description 9
- 230000003078 antioxidant effect Effects 0.000 description 9
- 230000001105 regulatory effect Effects 0.000 description 9
- 206010007247 Carbuncle Diseases 0.000 description 8
- UILPJVPSNHJFIK-UHFFFAOYSA-N Paeonol Chemical compound COC1=CC=C(C(C)=O)C(O)=C1 UILPJVPSNHJFIK-UHFFFAOYSA-N 0.000 description 8
- 230000000844 anti-bacterial effect Effects 0.000 description 8
- 229930003935 flavonoid Natural products 0.000 description 8
- 150000002215 flavonoids Chemical class 0.000 description 8
- 235000017173 flavonoids Nutrition 0.000 description 8
- 230000006870 function Effects 0.000 description 8
- 230000001737 promoting effect Effects 0.000 description 7
- 229930182490 saponin Natural products 0.000 description 7
- 150000007949 saponins Chemical class 0.000 description 7
- 235000017709 saponins Nutrition 0.000 description 7
- 230000035922 thirst Effects 0.000 description 7
- 206010027514 Metrorrhagia Diseases 0.000 description 6
- 208000002193 Pain Diseases 0.000 description 6
- 206010037660 Pyrexia Diseases 0.000 description 6
- 230000002950 deficient Effects 0.000 description 6
- 208000001780 epistaxis Diseases 0.000 description 6
- 230000002401 inhibitory effect Effects 0.000 description 6
- 230000007935 neutral effect Effects 0.000 description 6
- 230000036407 pain Effects 0.000 description 6
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 6
- 238000005728 strengthening Methods 0.000 description 6
- 208000011580 syndromic disease Diseases 0.000 description 6
- 235000018553 tannin Nutrition 0.000 description 6
- 229920001864 tannin Polymers 0.000 description 6
- 239000001648 tannin Substances 0.000 description 6
- 235000019640 taste Nutrition 0.000 description 6
- 201000000736 Amenorrhea Diseases 0.000 description 5
- 206010001928 Amenorrhoea Diseases 0.000 description 5
- 206010011224 Cough Diseases 0.000 description 5
- 108020004414 DNA Proteins 0.000 description 5
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 5
- 208000034507 Haematemesis Diseases 0.000 description 5
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 5
- 229930182558 Sterol Natural products 0.000 description 5
- 231100000540 amenorrhea Toxicity 0.000 description 5
- 230000006378 damage Effects 0.000 description 5
- 208000002173 dizziness Diseases 0.000 description 5
- 208000001848 dysentery Diseases 0.000 description 5
- 235000008434 ginseng Nutrition 0.000 description 5
- 229930182470 glycoside Natural products 0.000 description 5
- 150000002338 glycosides Chemical class 0.000 description 5
- 230000036039 immunity Effects 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 210000005259 peripheral blood Anatomy 0.000 description 5
- 239000011886 peripheral blood Substances 0.000 description 5
- 206010034754 petechiae Diseases 0.000 description 5
- 150000003432 sterols Chemical class 0.000 description 5
- 235000003702 sterols Nutrition 0.000 description 5
- 235000000346 sugar Nutrition 0.000 description 5
- 241000382455 Angelica sinensis Species 0.000 description 4
- 102000053602 DNA Human genes 0.000 description 4
- 235000002723 Dioscorea alata Nutrition 0.000 description 4
- 235000005362 Dioscorea floribunda Nutrition 0.000 description 4
- 235000004868 Dioscorea macrostachya Nutrition 0.000 description 4
- 235000005361 Dioscorea nummularia Nutrition 0.000 description 4
- 235000005360 Dioscorea spiculiflora Nutrition 0.000 description 4
- 208000005171 Dysmenorrhea Diseases 0.000 description 4
- 206010013935 Dysmenorrhoea Diseases 0.000 description 4
- 244000303040 Glycyrrhiza glabra Species 0.000 description 4
- 208000000616 Hemoptysis Diseases 0.000 description 4
- 241001672981 Purpura Species 0.000 description 4
- 208000025747 Rheumatic disease Diseases 0.000 description 4
- 210000000988 bone and bone Anatomy 0.000 description 4
- 235000004879 dioscorea Nutrition 0.000 description 4
- 239000012530 fluid Substances 0.000 description 4
- 230000002439 hemostatic effect Effects 0.000 description 4
- 230000002519 immonomodulatory effect Effects 0.000 description 4
- YLTGFGDODHXMFB-UHFFFAOYSA-N isoacetovanillon Natural products COC1=CC=C(C(C)=O)C=C1O YLTGFGDODHXMFB-UHFFFAOYSA-N 0.000 description 4
- 210000003127 knee Anatomy 0.000 description 4
- 230000005906 menstruation Effects 0.000 description 4
- 210000000056 organ Anatomy 0.000 description 4
- MLIBGOFSXXWRIY-UHFFFAOYSA-N paeonol Natural products COC1=CC=C(O)C(C(C)=O)=C1 MLIBGOFSXXWRIY-UHFFFAOYSA-N 0.000 description 4
- 230000002028 premature Effects 0.000 description 4
- 230000000552 rheumatic effect Effects 0.000 description 4
- 208000006820 Arthralgia Diseases 0.000 description 3
- 244000025254 Cannabis sativa Species 0.000 description 3
- 206010014080 Ecchymosis Diseases 0.000 description 3
- 208000037093 Menstruation Disturbances Diseases 0.000 description 3
- 206010027339 Menstruation irregular Diseases 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 206010033557 Palpitations Diseases 0.000 description 3
- 208000004078 Snake Bites Diseases 0.000 description 3
- 208000009205 Tinnitus Diseases 0.000 description 3
- 208000025865 Ulcer Diseases 0.000 description 3
- 230000003213 activating effect Effects 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 230000002929 anti-fatigue Effects 0.000 description 3
- 230000002785 anti-thrombosis Effects 0.000 description 3
- 230000000840 anti-viral effect Effects 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 230000001684 chronic effect Effects 0.000 description 3
- 210000002216 heart Anatomy 0.000 description 3
- 230000036737 immune function Effects 0.000 description 3
- 230000002757 inflammatory effect Effects 0.000 description 3
- -1 iodine, vitamin D Chemical class 0.000 description 3
- 210000000265 leukocyte Anatomy 0.000 description 3
- 201000004792 malaria Diseases 0.000 description 3
- 230000004792 oxidative damage Effects 0.000 description 3
- 230000037361 pathway Effects 0.000 description 3
- 150000002989 phenols Chemical class 0.000 description 3
- 150000008442 polyphenolic compounds Chemical class 0.000 description 3
- 235000013824 polyphenols Nutrition 0.000 description 3
- 230000004224 protection Effects 0.000 description 3
- 238000010791 quenching Methods 0.000 description 3
- 238000010025 steaming Methods 0.000 description 3
- 206010043554 thrombocytopenia Diseases 0.000 description 3
- 231100000886 tinnitus Toxicity 0.000 description 3
- 150000003648 triterpenes Chemical class 0.000 description 3
- 231100000397 ulcer Toxicity 0.000 description 3
- 239000000341 volatile oil Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 206010008479 Chest Pain Diseases 0.000 description 2
- 241000721047 Danaus plexippus Species 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 208000010201 Exanthema Diseases 0.000 description 2
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 2
- 240000002045 Guettarda speciosa Species 0.000 description 2
- 235000001287 Guettarda speciosa Nutrition 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 208000006877 Insect Bites and Stings Diseases 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- 206010041497 Spermatorrhoea Diseases 0.000 description 2
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 230000002921 anti-spasmodic effect Effects 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 239000003146 anticoagulant agent Substances 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 235000019658 bitter taste Nutrition 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- YCIMNLLNPGFGHC-UHFFFAOYSA-N catechol Chemical compound OC1=CC=CC=C1O YCIMNLLNPGFGHC-UHFFFAOYSA-N 0.000 description 2
- 239000000812 cholinergic antagonist Substances 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 230000009266 disease activity Effects 0.000 description 2
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 201000005884 exanthem Diseases 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 229930182494 ginsenoside Natural products 0.000 description 2
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 2
- 229960004949 glycyrrhizic acid Drugs 0.000 description 2
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 2
- 235000019410 glycyrrhizin Nutrition 0.000 description 2
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 2
- 208000035861 hematochezia Diseases 0.000 description 2
- 208000006750 hematuria Diseases 0.000 description 2
- 230000011132 hemopoiesis Effects 0.000 description 2
- 208000014617 hemorrhoid Diseases 0.000 description 2
- 230000002443 hepatoprotective effect Effects 0.000 description 2
- 208000006278 hypochromic anemia Diseases 0.000 description 2
- 210000002865 immune cell Anatomy 0.000 description 2
- 210000000987 immune system Anatomy 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- IYRMWMYZSQPJKC-UHFFFAOYSA-N kaempferol Chemical compound C1=CC(O)=CC=C1C1=C(O)C(=O)C2=C(O)C=C(O)C=C2O1 IYRMWMYZSQPJKC-UHFFFAOYSA-N 0.000 description 2
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 210000001165 lymph node Anatomy 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 210000000653 nervous system Anatomy 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- 230000036542 oxidative stress Effects 0.000 description 2
- 230000008506 pathogenesis Effects 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 2
- 206010037844 rash Diseases 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 230000035882 stress Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 description 1
- CTBBEXWJRAPJIZ-VHPBLNRZSA-N (1S,2S,3S,6R,8R,9S,10R)-2-benzoyl-1,3,8,10-tetrahydroxy-9-(4-methoxy-6-oxopyran-2-yl)-5-oxatricyclo[4.3.1.03,8]decan-4-one Chemical compound O1C(=O)C=C(OC)C=C1[C@H]1[C@]([C@@H]2O)(O)[C@H](C(=O)C=3C=CC=CC=3)[C@@]3(O)C(=O)O[C@@H]2C[C@]31O CTBBEXWJRAPJIZ-VHPBLNRZSA-N 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 1
- WAPNOHKVXSQRPX-UHFFFAOYSA-N 1-phenylethanol Chemical class CC(O)C1=CC=CC=C1 WAPNOHKVXSQRPX-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 244000205574 Acorus calamus Species 0.000 description 1
- 235000006480 Acorus calamus Nutrition 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 206010065360 Anal prolapse Diseases 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 208000010392 Bone Fractures Diseases 0.000 description 1
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 102000016918 Complement C3 Human genes 0.000 description 1
- 108010028780 Complement C3 Proteins 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- UBSCDKPKWHYZNX-UHFFFAOYSA-N Demethoxycapillarisin Natural products C1=CC(O)=CC=C1OC1=CC(=O)C2=C(O)C=C(O)C=C2O1 UBSCDKPKWHYZNX-UHFFFAOYSA-N 0.000 description 1
- 206010012741 Diarrhoea haemorrhagic Diseases 0.000 description 1
- 235000007056 Dioscorea composita Nutrition 0.000 description 1
- 235000009723 Dioscorea convolvulacea Nutrition 0.000 description 1
- 206010013789 Dry throat Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- CTBBEXWJRAPJIZ-UHFFFAOYSA-N Enterocin Natural products O1C(=O)C=C(OC)C=C1C1C(C2O)(O)C(C(=O)C=3C=CC=CC=3)C3(O)C(=O)OC2CC31O CTBBEXWJRAPJIZ-UHFFFAOYSA-N 0.000 description 1
- 206010017076 Fracture Diseases 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 206010018276 Gingival bleeding Diseases 0.000 description 1
- 241000202807 Glycyrrhiza Species 0.000 description 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- 206010061191 Haemorrhage foetal Diseases 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 206010019837 Hepatocellular injury Diseases 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 235000015466 Hierochloe odorata Nutrition 0.000 description 1
- 208000033830 Hot Flashes Diseases 0.000 description 1
- 206010060800 Hot flush Diseases 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- 235000006350 Ipomoea batatas var. batatas Nutrition 0.000 description 1
- 206010023232 Joint swelling Diseases 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 244000286695 Melinis minutiflora var. inermis Species 0.000 description 1
- 229920000715 Mucilage Polymers 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- 244000170916 Paeonia officinalis Species 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- YKRGDOXKVOZESV-WRJNSLSBSA-N Paeoniflorin Chemical compound C([C@]12[C@H]3O[C@]4(O)C[C@](O3)([C@]1(C[C@@H]42)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)C)OC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-WRJNSLSBSA-N 0.000 description 1
- QFJUYMMIBFBOJY-UXZRXANASA-N Panaxatriol Chemical compound C[C@]1([C@H]2CC[C@@]3([C@@H]2[C@H](O)C[C@H]2[C@]3(C[C@@H](O)[C@H]3C(C)(C)[C@@H](O)CC[C@@]32C)C)C)CCCC(C)(C)O1 QFJUYMMIBFBOJY-UXZRXANASA-N 0.000 description 1
- VIXIMKLMEZTTTC-UHFFFAOYSA-N Panaxatriol Natural products CC1(C)CCCC(O1)C2CCC3(C)C2C(O)CC4C5(C)CCC(O)C(C)(C)C5C(O)CC34C VIXIMKLMEZTTTC-UHFFFAOYSA-N 0.000 description 1
- 241001213934 Panicum schinzii Species 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 208000008469 Peptic Ulcer Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- 241000405414 Rehmannia Species 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- 241000581682 Sanguisorba Species 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- 241000270295 Serpentes Species 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000030695 Sparse hair Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- DWCSNWXARWMZTG-UHFFFAOYSA-N Trigonegenin A Natural products CC1C(C2(CCC3C4(C)CCC(O)C=C4CCC3C2C2)C)C2OC11CCC(C)CO1 DWCSNWXARWMZTG-UHFFFAOYSA-N 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 238000007792 addition Methods 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001780 adrenocortical effect Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000000954 anitussive effect Effects 0.000 description 1
- 230000003288 anthiarrhythmic effect Effects 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000002429 anti-coagulating effect Effects 0.000 description 1
- 230000001430 anti-depressive effect Effects 0.000 description 1
- 230000003172 anti-dna Effects 0.000 description 1
- 230000002019 anti-mutation Effects 0.000 description 1
- 230000002467 anti-pepsin effect Effects 0.000 description 1
- 230000000702 anti-platelet effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 230000002180 anti-stress Effects 0.000 description 1
- 239000003416 antiarrhythmic agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 239000000935 antidepressant agent Substances 0.000 description 1
- 229940005513 antidepressants Drugs 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 229940124584 antitussives Drugs 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N benzo-alpha-pyrone Natural products C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000003177 cardiotonic effect Effects 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 210000003756 cervix mucus Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 230000003920 cognitive function Effects 0.000 description 1
- 230000024203 complement activation Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 235000008504 concentrate Nutrition 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 235000001671 coumarin Nutrition 0.000 description 1
- 229930182483 coumarin glycoside Natural products 0.000 description 1
- 150000008140 coumarin glycosides Chemical class 0.000 description 1
- 150000004775 coumarins Chemical class 0.000 description 1
- 229930182485 cyanogenic glycoside Natural products 0.000 description 1
- 150000008142 cyanogenic glycosides Chemical class 0.000 description 1
- 230000003808 decrease of hair loss Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- WQLVFSAGQJTQCK-VKROHFNGSA-N diosgenin Chemical compound O([C@@H]1[C@@H]([C@]2(CC[C@@H]3[C@@]4(C)CC[C@H](O)CC4=CC[C@H]3[C@@H]2C1)C)[C@@H]1C)[C@]11CC[C@@H](C)CO1 WQLVFSAGQJTQCK-VKROHFNGSA-N 0.000 description 1
- WQLVFSAGQJTQCK-UHFFFAOYSA-N diosgenin Natural products CC1C(C2(CCC3C4(C)CCC(O)CC4=CCC3C2C2)C)C2OC11CCC(C)CO1 WQLVFSAGQJTQCK-UHFFFAOYSA-N 0.000 description 1
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 1
- 239000007919 dispersible tablet Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 150000004141 diterpene derivatives Chemical class 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 229960003638 dopamine Drugs 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 210000005069 ears Anatomy 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 239000007938 effervescent tablet Substances 0.000 description 1
- 230000002996 emotional effect Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 1
- 235000001785 ferulic acid Nutrition 0.000 description 1
- 229940114124 ferulic acid Drugs 0.000 description 1
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 229920002824 gallotannin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 229920000591 gum Polymers 0.000 description 1
- 208000024963 hair loss Diseases 0.000 description 1
- 230000003676 hair loss Effects 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000002489 hematologic effect Effects 0.000 description 1
- 210000001624 hip Anatomy 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940125698 hormone suppressant Drugs 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 208000026278 immune system disease Diseases 0.000 description 1
- 230000001506 immunosuppresive effect Effects 0.000 description 1
- 229960003444 immunosuppressant agent Drugs 0.000 description 1
- 239000003018 immunosuppressive agent Substances 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000000749 insecticidal effect Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 159000000014 iron salts Chemical class 0.000 description 1
- 210000001503 joint Anatomy 0.000 description 1
- 235000008777 kaempferol Nutrition 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 239000008141 laxative Substances 0.000 description 1
- 230000002475 laxative effect Effects 0.000 description 1
- 229940010454 licorice Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 231100000849 liver cell damage Toxicity 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 230000007087 memory ability Effects 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229930003658 monoterpene Natural products 0.000 description 1
- 150000002773 monoterpene derivatives Chemical class 0.000 description 1
- 235000002577 monoterpenes Nutrition 0.000 description 1
- UXOUKMQIEVGVLY-UHFFFAOYSA-N morin Natural products OC1=CC(O)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 UXOUKMQIEVGVLY-UHFFFAOYSA-N 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 230000037257 muscle growth Effects 0.000 description 1
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 description 1
- 229960002715 nicotine Drugs 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- YKRGDOXKVOZESV-UHFFFAOYSA-N paeoniflorin Natural products O1C(C)(C2(CC34)OC5C(C(O)C(O)C(CO)O5)O)CC3(O)OC1C24COC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-UHFFFAOYSA-N 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- XFDQJKDGGOEYPI-UHFFFAOYSA-O peonidin Chemical compound C1=C(O)C(OC)=CC(C=2C(=CC=3C(O)=CC(O)=CC=3[O+]=2)O)=C1 XFDQJKDGGOEYPI-UHFFFAOYSA-O 0.000 description 1
- 229930015721 peonidin Natural products 0.000 description 1
- 235000006404 peonidin Nutrition 0.000 description 1
- 208000011906 peptic ulcer disease Diseases 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 235000009048 phenolic acids Nutrition 0.000 description 1
- 150000007965 phenolic acids Chemical class 0.000 description 1
- 229930015704 phenylpropanoid Natural products 0.000 description 1
- 125000001474 phenylpropanoid group Chemical group 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 229940068065 phytosterols Drugs 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 230000003334 potential effect Effects 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 230000000405 serological effect Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 150000003577 thiophenes Chemical class 0.000 description 1
- DSNBHJFQCNUKMA-SCKDECHMSA-N thromboxane A2 Chemical compound OC(=O)CCC\C=C/C[C@@H]1[C@@H](/C=C/[C@@H](O)CCCCC)O[C@@H]2O[C@H]1C2 DSNBHJFQCNUKMA-SCKDECHMSA-N 0.000 description 1
- 230000003867 tiredness Effects 0.000 description 1
- 208000016255 tiredness Diseases 0.000 description 1
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 150000008130 triterpenoid saponins Chemical class 0.000 description 1
- 206010046901 vaginal discharge Diseases 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
一种治疗系统性红斑狼疮相关免疫性血小板减少症的益气养阴祛瘀复方中药,属于复方中药制剂技术领域。该益气养阴祛瘀复方中药由黄芪、黄精、党参、西洋参、红景天、山药、女贞子、墨旱莲、鳖甲、丹参、地榆、苎麻根、紫珠、仙鹤草以及熟地黄等中药组成。该病为本虚标实、虚实夹杂之证,脾肾气阴两虚为本,络热血瘀毒蕴为标。脾失运化,生化无源,脾不统血,血不归经;肾虚阴亏,血虚络滞,则邪毒蕴结;邪热燔灼真阴,耗伤阴血,则肾虚阴亏更甚;邪毒火热搏结于血分,血脉瘀滞则为瘀血,终成本虚标实、虚实夹杂之证。因此本发明选择以上诸药共用,有益气养阴,清热凉血祛瘀之效,针对系统性红斑狼疮相关免疫性血小板减少症具有较好的治疗效果。
Description
技术领域
本发明属于复方中药制剂技术领域,具体是涉及一种治疗系统性红斑狼疮相关免疫性血小板减少症的益气养阴祛瘀复方中药。
背景技术
免疫性血小板减少(Immune thrombocytopenia,ITP)是系统性红斑狼疮常见的血液学表现,可单独发生或引起其他器官损伤;SLE相关免疫性血小板减少症(SLE-ITP)是系统性红斑狼疮发作的危险因素,患病率约为7%-30%;ITP具有异质性,可以是慢性的、无症状的、急性的或重度的;临床表现为瘀斑、鼻出血、牙龈出血等,重度血小板减少可能导致严重的内脏出血;重度血小板减少症约占3%-20%,往往与SLE病程较长有关;重度血小板减少症是SLE的不良预后因素,且死亡率高。
目前SLE-ITP的治疗主要依赖激素和免疫抑制剂;然而仍然有1/3的患者对这些治疗无效,且患者经常反复接受大剂量GC和积极免疫抑制剂治疗,会增加患者的感染及其他风险;中医治疗风湿免疫性疾病具有独特的优势,因此人们对有效治疗SLE相关免疫性血小板减少症的中药药物存在极大的需求;但目前还没有针对SLE相关免疫性血小板减少症的中药方剂,往往是治疗系统性红斑狼疮的方剂,但SLE相关免疫性血小板减少症与系统性红斑狼疮的中医发病病机尚有区别,因此治疗方剂尚有区别,所以亟需有效治疗SLE相关免疫性血小板减少症的中药方剂。
发明内容
针对目前西医治疗药物及手段所存在的不足之处,本发明要解决的技术问题为提供一种治疗系统性红斑狼疮相关免疫性血小板减少症的益气养阴祛瘀复方中药。
为了实现上述目的,本发明所采用的技术方案为:
一种治疗系统性红斑狼疮相关免疫性血小板减少症的益气养阴祛瘀复方中药,其有效成分由如下重量份的中药原料制得:
该方中,各中药的药效如下:
黄芪,又名北芪、黄耆。味甘,性微温。归肺、脾经。具有健脾补中,升阳举陷,益卫固表,利尿,托毒生肌的功效。主治脾气虚证,肺气虚证,气虚自汗证,气血亏虚,疮疡难溃难腐,或溃久难敛等。现代药理学研究表明,黄芪含有多种活性成分,如黄芪多糖、黄芪皂苷、黄芪黄酮等成分,其中黄芪多糖的免疫调节作用被认为是其最重要的作用之一。
黄精,味甘,性平。归脾、肺、肾经。具有补气养阴,健脾,润肺,益肾的功效。主治脾胃气虚,体倦乏力,胃阴不足,口干食少,肺虚燥咳,劳嗽咳血,精血不足,腰膝酸软,须发早白,内热消渴。现代药理学研究发现,黄精具有多种生物活性成分,如黄精中的多糖类物质被发现具有免疫调节作用,能够增强机体免疫功能;黄精甙等,有助于清除体内自由基,减轻氧化应激对细胞的损害,从而对抗衰老和慢性疾病的发生具有一定的保护作用;除此之外,还具有抗炎、调节血糖、降低血压、抑制血小板聚集等作用。
党参,具有健脾益肺、养血生津之功效。主治脾胃虚弱,气血两亏,体倦无力,食少,口渴,久泻,脱肛。现代药理研究表明,党参中含有多糖类、皂苷等成分,具有显著的免疫调节作用。其中一些化合物,如皂苷和多酚类物质,表现出抗氧化活性,对于预防氧化性损伤相关的疾病具有潜在的保护作用。还具有抗炎、抗疲劳、保护心血管等作用。
西洋参,甘微苦,凉。具有益肺阴,清虚火,生津止渴的功效。主治肺虚久嗽,失血,咽干口渴,虚热烦倦。现代药理学研究表明西洋参中含有人参皂苷、多糖等成分,这些成分被认为能够增强免疫系统功能,促进免疫细胞的活性,提高机体的抵抗力。而人参皂苷和人参三醇等物质表现出较强的抗氧化活性,还可以抑制炎症因子的释放,减轻炎症反应。另外西洋参被广泛应用于提高精力、改善认知功能、减轻疲劳等方面。其成分能够促进神经系统的活动,增强机体的应激能力。
红景天,又名蔷薇红景天,扫罗玛布尔。味甘、苦、性平、归肺、心经。具有益气活血,通脉平喘之功。主要用于气虚血瘀,胸痹心痛,中风偏瘫,倦怠气喘。现代药理学研究发现红景天能够增加机体对各种应激因素的适应性,提高身体的耐受力,并减轻疲劳感,具有抗疲劳和抗应激作用。红景天中的苯乙醇类、黄酮类等成分具有抗氧化活性,在抗衰老和防治氧化性损伤方面显示出潜在的作用。另外还具有提高学习和记忆能力,对改善情绪状态、缓解抑郁和焦虑症状作用,对于心血管系统、免疫系统具有一定的调节作用。
山药,甘,平。归脾、肺、肾经。具有补脾养胃,生津益肺,补肾涩精的功效。用治脾虚泄泻,久痢,虚劳咳嗽,消渴,遗精、带下,小便频数。山药块茎含薯蓣皂甙元、多巴胺、盐酸山药碱、氨基酸、多糖、多种甾醇成分,其中多糖类物质具有免疫调节作用,可以增强机体的免疫功能,促进免疫细胞的活性;多酚类化合物,有助于清除自由基,减缓细胞的氧化损伤。另外山药还具有抗炎、调节血糖、改善消化系统的作用。
女贞子,甘、苦,凉。归肝、肾经。具有滋补肝肾,明目乌发的功效。主治用于眩晕耳鸣,腰膝酸软,须发早白,目暗不明。其现代药理学研究表明,女贞子含有多种生物活性成分,如苦苷、三萜皂苷等,被认为具有免疫调节作用;多酚类化合物,具有抗氧化活性;另外还具有抗炎、降糖、降血脂及抗动脉硬化、改善肝细胞损伤、调节免疫、升高血三系的作用。
墨旱莲,甘、酸,寒。归肾、肝经。功效滋补肝肾,凉血止血。用于牙齿松动,须发早白,眩晕耳鸣,腰膝酸软,阴虚血热、吐血、衄血、尿血,血痢,崩漏下血,外伤出血。现代药理学研究表明其全草含皂甙、烟碱、鞣质、维生素A、鳢肠素等多种噻吩化合物,具有止血、改善循环、镇静、镇痛等作用。
鳖甲,咸,微寒。归肝、肾经。具有滋阴潜阳,退热除蒸,软坚散结之功效。常用于阴虚发热,骨蒸劳热,阴虚阳亢,头晕目眩,虚风内动,经闭,癥瘕,久疟疟母。现代药理学研究表明鳖甲含动物胶、角蛋白、碘质、维生素D等成分。具有抗疲劳作用、增强免疫、抗炎、改善神经系统功能的作用。
拳参,苦、涩,微寒。归肺、肝、大肠经。有清热解毒,消肿,止血之功效,常用于赤痢热泻,肺热咳嗽,痈肿瘰疬,口舌生疮,血热吐衄,痔疮出血,蛇虫咬伤。现代药理研究发现拳参含有鞣质、淀粉、糖类及果胶、树胶、粘液质、树脂等成分。拳参渗滤液与明胶制成的制剂有一定的止血作用,皂苷等成分被认为对血液有调节作用,能够抑制血小板聚集,具有抗凝血和抗栓形成的效果。除此之外,还具有抗菌、抗炎等作用。
生地黄,味甘、苦,性寒。归心、肝、肺经。有清热凉血,养阴,生津之功。用于热病舌绛烦渴,阴虚内热,骨蒸劳热,内热消渴,吐血,衄血,发斑发疹。生地黄中如糖苷、生地黄苷等,被认为具有一定的抗炎作用;多糖可增强细胞免疫功能;黄酮类化合物,具有抗氧化活性。另外生地黄还具有止血、抑制血小板聚集的功能。
丹皮,苦、辛,微寒。归心、肝、肾经。具有清热凉血、活血化瘀的功效。主治热入营血,温毒发斑,吐血衄血,夜热早凉,无汗骨蒸,经闭痛经,跌扑伤痛,痈肿疮毒。现代研究证明,牡丹皮主要含丹皮酚(即芍药醇)、牡丹皮原甙、苯甲酸、植物甾醇、鞣质等化学成分。具有保肝护肾、抗炎、镇静、降温、解热、镇痛、解痉等多种药理作用。
肿节风,味苦、辛,性平。归心、肝经。功效清热凉血,活血消斑,祛风通络。用于血热紫斑、紫癜,风湿痹痛,跌打损伤。现代药理学研究发现肿节风含挥发油、酯类、酚类、鞣质、黄酮、氰甙、香豆素、内酯。具有抗肿瘤、抗菌、抗病毒、促进骨折愈合、抗血小板聚集等作用。
地榆,味苦、酸、涩,微寒。归肝、大肠经。具有凉血止血,解毒敛疮的功效。用于便血,痔血,血痢,崩漏,水火烫伤,痈肿疮毒。现代药理学研究表明地榆主要成分槲皮素、地榆皂苷、山柰酚等具有升高白细胞、血小板的作用。还具有抗炎、抑制炎症介质释放、调节免疫、抗氧化等药理作用。
苎麻根,有凉血止血,安胎,清热解毒之功。主治血热妄行所致的咯血;吐血;衄血;血淋;便血;崩漏;紫癜;胎动不安;胎漏下血;小便淋沥;痈疮肿毒;虫蛇咬伤。根含有酚类、三萜(或甾醇)、绿原酸、黄酮类、香豆精甙类、有机酸类、生物碱、氨基酸及多糖类等成分。其中酚类、三萜(或甾醇)具有止血的作用。另外苎麻根还具有升高血小板、白细胞,抗菌、抗炎、抗氧化等作用。
紫珠,归肝、肺、胃经。具有收敛止血,清热解毒之功效。常用于咯血,呕血,衄血,牙龈出血,尿血,便血,崩漏,皮肤紫癜,外伤出血,痈疽肿毒,毒蛇咬伤,烧伤。现代药理学研究表明紫珠包含黄酮类、苯丙素类、萜类和挥发油类中性树脂、糖类、羟基化合物及镁、钙、铁盐等成分。具有抗炎、止血、抗菌、调节免疫和保肝等作用。
仙鹤草,苦,涩,平。归心、肝经。具有收敛止血,截疟,止痢,解毒,补虚的功效。用于咯血,吐血,崩漏下血,疟疾,血痢,痈肿疮毒,阴痒带下,脱力劳伤。现代研究发现仙鹤草全草含仙鹤草素、仙鹤草内酯、鞣质(为焦性儿茶酚鞣质、没食子鞣质等)、甾醇、有机酸、皂甙、酚性成分等。其中仙鹤草素有促进凝血作用,另外还具有抗炎、强心、抗菌、抗病毒、杀虫的功效。
丹参,味苦,微寒。归心、肝经。具有活血祛瘀,通经止痛,清心除烦,凉血消痈之功效。用于胸痹心痛,脘腹胁痛,症瘕积聚,热痹疼痛,心烦不眠,月经不调,痛经经闭,疮疡肿痛。现代药理学研究发丹参根主含脂溶性的二萜类成分和水溶性的酚酸成分,还含黄酮类、三萜类、甾醇等其他成分。具有抗血栓形成、抑制血小板聚集(提高血小板内cAMP水平抑制TXA2合成)、改善微循环、抗菌、降脂的作用。
熟地黄,味甘,性微温。归肝、肾经。具有滋阴补血,益精填髓的功效。用于肝肾阴虚,腰膝酸软,骨蒸潮热,盗汗遗精,内热消渴,血虚萎黄,心悸怔忡,月经不调,崩漏下血,眩晕,耳鸣,须发早白。现代药理学研究表明,熟地黄含较少量的环烯醚匝类、单萜、氨基酸等成分。具有刺激骨髓造血、促进红细胞生成和改善贫血的作用。而糖苷类化合物,被认为具有一定的抗炎作用;黄酮类化合物,具有抗氧化活性,有助于清除体内的自由基,减缓氧化应激对细胞的损害。除此之外,还具有调节免疫、保肝、抗抑郁的作用。
当归,味甘、辛,性温。归肝、心、脾经。功能补血活血,调经止痛,润肠通便。主治血虚萎黄,眩晕心悸,月经不调,经闭痛经,虚寒腹痛,肠燥便秘,风湿痹痛,跌扑损伤,痈疽疮疡。酒当归活血通经。用于经闭痛经,风湿痹痛,跌扑损伤。现代药理研究发现当归含挥发油,蔗糖、维生素、脂肪酸等成分。当归多糖促进造血(升高外周血红细胞、白细胞、血红蛋白等含量)的功效;当归多糖、阿魏酸增强免疫。还具有抑制血小板聚集、抗血栓形成、抗炎、抗菌、抗氧化的作用。
炙甘草,又名胀果甘草、光果甘草、炙草、灵草、灵通、甜草、甜根子、西草、东草甘、国老、粉甘草、粉草、蜜草、主人、汾草。味甘,性平。归心、肺、脾胃经。具有补脾和胃、益气复脉的功效。治脾胃虚弱,倦怠乏力,心动悸,脉结代。现代研究结果显示,炙甘草中甘草酸和甘草甜素等成分能够抑制炎症介质的释放,减轻炎症反应;另外还具有抗消化性溃疡、保肝、解痉、抗心律失常、镇咳祛痰、解毒、抗炎、抗菌、抗病毒、抗变态反应、肾上腺皮质激素样作用以及抗肿瘤、抗突变等多种药理作用。
中医认为,系统性红斑狼疮相关免疫性血小板减少症病机病机是以脾肾气阴两虚为本,络热血瘀毒蕴为标。先天禀赋不足,脾肾亏虚,女子体阴而用阳,精血不足,阴阳失调,血脉不通,瘀滞脏腑、关节而成痹证。并将其归属于“红蝴蝶疮”、“蝴蝶斑”、“阴阳毒”范畴。脾为气血生化之源,五脏精气皆由脾所资,生成人体营卫之气,助人体抵御外邪。脾气亏虚,脾运化功能减弱,则正气亏虚,脾气无法统摄血液,血不归经,易致皮肤瘀斑出血。人体正气既虚,邪气夹杂热毒搏结于血分,煎灼血中津液,使血液黏稠而运行不畅;或热灼脉络,迫血妄行导致内出血,以致血液壅滞于皮肤等部位而成瘀血。而正如《血证论·男女异同论》所述:“瘀血不行,则新血断无生理……盖瘀血去则新血易生,新血生而瘀血自去。”或可阻滞经脉,导致气血运行不利,形体官窍因脉络瘀阻,可见口唇、爪甲青紫,皮肤瘀点瘀斑,舌有瘀点、瘀斑,脉涩不畅等。肾主藏精,肾精不足,脏腑无精血漂养,易致气血阴阳失调。本病虚、瘀、毒三者并存,互为因果。肾虚阴亏,血虚络滞,则邪毒易于蕴结;邪热燔灼真阴,耗伤阴血,则肾虚阴亏更甚;邪毒火热搏结于血分,血脉瘀滞则为瘀血,终成本虚标实、虚实夹杂之证。
该病涉及脾、肾脏,则治疗上以益气养阴为主,兼有健脾化湿、清热凉血祛瘀之法;二者兼顾可阻断其恶性循环。所以本病以虚为主,兼夹瘀血的疾病特点,治疗上需标本兼顾,兼补虚逐邪举措,治疗效果更显。中医治疗有“治病求本,虚补实泻”的大纲,本发明拟方“益气养阴,清热凉血祛瘀方”以此为据,以“益气养阴,清热凉血祛瘀”为治疗总则,疗效颇佳。
此复方中黄芪甘温益气,补在表之卫气,《本草再新》记载:“夫黄耆乃补气、补血之圣品……盖气无形,血亦有形。”黄精甘平,补气养阴,健脾益肾,重于养阴。两药合用,气阴并补,脾肾兼顾,共为君药。臣药中党参、山药味甘、性平,具有益气健脾养血生津之效,助黄芪、黄精补益脾肾气阴之功;女贞子,甘苦而凉,善能滋补肝肾之阴;墨旱莲甘酸而寒,补养肝肾之阴,又凉血止血。二药性皆平和,补养肝肾之精,而不滋腻,伍用有平补肝肾之效,使精血得充,辅以鳖甲咸寒滋阴潜阳,增强滋阴之效。西洋参性凉,养阴生津兼清虚火,生地气寒,气薄味浓,沉也,阴中阳也。《药鉴》曰:“生地……能凉血泻热,清脾土湿热,除五心烦热。”二者合用防止君药补益太过而生燥伤阴,有祛邪不伤正,扶正不留邪之义。邪气久羁,正气亏虚,瘀热内蕴,气虚无力推动血行而致瘀血留滞,伍用红景天益气活血通脉;热迫血行,斑疹隐隐,地榆、紫珠、仙鹤草苦涩,收敛止血;苎麻根、丹皮、肿节风、拳参清热凉血止血,而丹皮、肿节风兼具活血化瘀之效,使凉血止血不留瘀;瘀血阻滞经脉,气血运行不利,形体官窍因脉络瘀阻,出现皮肤瘀斑瘀点,佐以丹参平而走血,主去瘀而生新;熟地黄滋阴补血、对肾阴不足滋补尤甚,臣药中山药健脾养胃、补肾补脾,两药协同共奏滋补脾肾之效。辅以当归补血活血,使其补益而不留瘀。炙甘草补脾和胃,调和诸药而为使药。全方益气养阴,清热凉血祛瘀,补益而不留瘀、祛邪而不伤正。
以上诸药共用,有益气养阴,清热凉血祛瘀,补益而不留瘀、祛邪而不伤正;针对系统性红斑狼疮相关免疫性血小板减少症具有较好的治疗效果。
作为本发明的优选技术方案,其有效成分优选由如下重量份的中药原料制得:
作为本发明的优选技术方案,其有效成分进一步优选由如下重量份的中药原料制得:
本发明所提出的这种系统性红斑狼疮相关免疫性血小板减少症的益气养阴祛瘀复方中药,可依照常规中药复方制备方法,制成药煎剂、凝胶剂、凝胶膏剂、软膏剂、片剂、胶囊剂、颗粒剂、滴丸剂、口服液、丸剂、糖浆剂、分散片或泡腾片。制成中药药煎剂服用效果最佳。
附图说明
图1治疗前、后两组MRL/lpr鼠dsDNA、C3比较。
图2治疗前、后两组MRL/lpr鼠外周血血小板相关参数比较。
具体实施方式
以下结合附图和实施例对本发明的治疗系统性红斑狼疮相关免疫性血小板减少症的益气养阴祛瘀复方中药作进一步的详述。
实施例1
将25g黄芪、12g黄精、12g党参、6g西洋参、6g红景天、12g山药、10g女贞子、10g墨旱莲、20g鳖甲、12g丹参、12g地榆、12g苎麻根、12g紫珠、10g仙鹤草、12g熟地黄、10g当归、10g拳参、12g生地黄、10g丹皮、12g肿节风、8g炙甘草混合,加入400g水,加热回流提取,过滤后再次加入250g水加热回流提取。合并两次滤液,浓缩得到约400mL药煎剂。
实施例2
动物试验
(1)实验分组与给药
将10只MRL/lpr雌性狼疮鼠随机分为对照组、观察组(中药汤剂组),每组5只;每组动物在常规饲养基础上用药,剂量按照各种实验动物间单位体表面积用药量相等原则进行药物换算,观察组(实施例1制备中药汤剂)按31.85g/Kg灌胃,正常对照组及模型组灌胃给予等量溶媒,每天固定时间给药1次,连续8周。
(2)指标检测
1)一般形态学观察
对照组毛发稀疏,有3只MRL/lpr狼疮鼠两颊及耳后毛发脱落,浅表淋巴结肿大、性情暴躁,观察组组较对照组毛发脱落情况发生较少,浅表淋巴结肿大情况改善,且性情温顺。
2)MRL/lpr狼疮鼠dsDNA、C3比较
末次给药24h后,眼底取血,离心获血清,ELISA法检测抗ds-DNA、C3浓度水平。与正常对照组比较,观察组MRL/lpr狼疮鼠dsDNA显著降低(P<0.05),C3显著降低(P<0.05),见图1。
3)MRL/lpr狼疮鼠外周血血小板相关参数
MRL/lpr狼疮鼠眼底取血,全自动五分类血液分析仪检测血小板相关参数;与正常对照组比较,观察组MRL/lpr狼疮鼠血小板(PLT)、血小板压积(PCT)、血小板分布宽度(PDW)显著升高(P<0.05),血小板平均体积(MPV)显著降低(P<0.05),见图2。
抗双链DNA抗体是抗DNA抗体中的一种,是系统性红斑狼疮SLE的血清学标志物;补体C3在补体经典激活途径和旁路激活途径中均发挥重要作用;dsDNA、C3水平与系统性红斑狼疮患者疾病活动度高度相关;实验表明,观察组(中药汤剂组)MRL/lpr狼疮鼠状态明显改善,疾病活动度显著降低。通过对血小板相关参数的比较,观察到观察组MRL/lpr狼疮鼠外周血PLT显著升高,PCT、PDW也有显著升高,MPV显著降低,PCT是通过血小板平均体积与血小板数量乘积换算而来,PDW是反映血液中血小板变异大小的参数,这些结果提示MRL/lpr狼疮鼠外周血PLT数量和质量均有显著提高。
因此,本发明所提出的这种益气养阴祛瘀复方中药能够用于系统性红斑狼疮相关免疫性血小板减少症的治疗,且具有良好的治疗效果。
以上内容仅仅是对本发明的构思所作的举例和说明,所属本技术领域的技术人员对所描述的具体实施例做各种各样的修改或补充或采用类似的方式替代,只要不偏离发明的构思或者超越本权利要求书所定义的范围,均应属于本发明的保护范围。
Claims (3)
1.一种治疗系统性红斑狼疮相关免疫性血小板减少症的益气养阴祛瘀复方中药,其特征在于,其有效成分由如下重量份的中药原料制得:
炙甘草 5~10份。
2.如权利要求1所述的治疗系统性红斑狼疮相关免疫性血小板减少症的益气养阴祛瘀复方中药,其特征在于,其有效成分由如下重量份的中药原料制得:
炙甘草 6~8份。
3.如权利要求2所述的治疗系统性红斑狼疮相关免疫性血小板减少症的益气养阴祛瘀复方中药,其特征在于,其有效成分由如下重量份的中药原料制得:
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202311858476.4A CN117752741B (zh) | 2023-12-30 | 2023-12-30 | 一种治疗系统性红斑狼疮相关免疫性血小板减少症的益气养阴祛瘀复方中药 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202311858476.4A CN117752741B (zh) | 2023-12-30 | 2023-12-30 | 一种治疗系统性红斑狼疮相关免疫性血小板减少症的益气养阴祛瘀复方中药 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN117752741A true CN117752741A (zh) | 2024-03-26 |
| CN117752741B CN117752741B (zh) | 2024-09-06 |
Family
ID=90318243
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202311858476.4A Active CN117752741B (zh) | 2023-12-30 | 2023-12-30 | 一种治疗系统性红斑狼疮相关免疫性血小板减少症的益气养阴祛瘀复方中药 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN117752741B (zh) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101966311A (zh) * | 2010-09-30 | 2011-02-09 | 黄毅 | 治疗红斑狼疮的中药制剂 |
| CN102284002A (zh) * | 2011-08-16 | 2011-12-21 | 成都绿迪科技有限公司 | 一种治疗红斑狼疮的中药 |
| CN102335336A (zh) * | 2010-07-22 | 2012-02-01 | 潘立芝 | 一种治疗红斑狼疮的中药 |
| CN109125653A (zh) * | 2018-09-26 | 2019-01-04 | 四川省益康源医疗器械有限公司 | 一种阴血亏虚型红斑狼疮治疗配方及其制备方法 |
-
2023
- 2023-12-30 CN CN202311858476.4A patent/CN117752741B/zh active Active
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102335336A (zh) * | 2010-07-22 | 2012-02-01 | 潘立芝 | 一种治疗红斑狼疮的中药 |
| CN101966311A (zh) * | 2010-09-30 | 2011-02-09 | 黄毅 | 治疗红斑狼疮的中药制剂 |
| CN102284002A (zh) * | 2011-08-16 | 2011-12-21 | 成都绿迪科技有限公司 | 一种治疗红斑狼疮的中药 |
| CN109125653A (zh) * | 2018-09-26 | 2019-01-04 | 四川省益康源医疗器械有限公司 | 一种阴血亏虚型红斑狼疮治疗配方及其制备方法 |
Non-Patent Citations (7)
| Title |
|---|
| SHUANGSHUANG SHANG, 等: "The protective effects of qihuang jianpi zishen decoction on mrl/lpr mice and its mechanism.", PAK J PHARM SCI., 30 November 2022 (2022-11-30), pages 1627 - 1635 * |
| 刘志勤;苏艾华;: "姜泉治疗系统性红斑狼疮经验", 中医杂志, vol. 50, no. 08, 17 August 2009 (2009-08-17), pages 691 - 692 * |
| 包祖晓: "升麻鳖甲汤治验3则", 新中医, vol. 33, no. 11, 15 November 2001 (2001-11-15), pages 61 - 62 * |
| 周宝宽;: "审证求因治疗系统性红斑狼疮", 世界科学技术(中医药现代化), vol. 14, no. 03, 20 June 2012 (2012-06-20), pages 1709 - 1712 * |
| 朱震;张世勤;高治国;汪悦;: "系统性红斑狼疮证型及用药规律现代文献研究", 中医杂志, vol. 57, no. 01, 2 January 2016 (2016-01-02), pages 71 - 74 * |
| 汤忠富,等: "芪黄健脾滋肾颗粒对系统性红斑狼疮血小板减少患者的临床疗效", 中成药, vol. 45, no. 6, 20 June 2023 (2023-06-20), pages 1845 - 1848 * |
| 臧利平;何夏秀;: "冯兴华教授辨证治疗系统性红斑狼疮验案三则", 环球中医药, no. 03, 6 March 2020 (2020-03-06), pages 116 - 118 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN117752741B (zh) | 2024-09-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6280751B1 (en) | Essential oil composition | |
| CN104127531B (zh) | 一种治疗肠胃炎的中药组合物及其制备方法 | |
| CN103432475B (zh) | 一种治疗过敏性鼻炎的中药组合物及其制备方法 | |
| CN103055116B (zh) | 一种治疗痤疮的中药组合物 | |
| CN104873705A (zh) | 一种治疗冠心病心绞痛的药物组合物及其应用 | |
| CN104825914A (zh) | 一种辅助治疗乳腺癌症的中药制剂 | |
| CN117599125B (zh) | 一种用于治疗骨质疏松症的补钙壮骨中药组合物及制法和应用 | |
| CN115252691B (zh) | 一种用于治疗气滞血瘀型冠心病心绞痛的中药组合物 | |
| CN117752741B (zh) | 一种治疗系统性红斑狼疮相关免疫性血小板减少症的益气养阴祛瘀复方中药 | |
| CN103652450A (zh) | 一种猪饲料及其制备方法 | |
| CN103611021A (zh) | 用于治疗猪膀胱炎的药物及其制备方法 | |
| CN103520644B (zh) | 用于治疗痰瘀型高脂血症的中药组合物及其制备方法 | |
| CN109876127B (zh) | 一种养血当归胶囊及其制备方法 | |
| CN104906345A (zh) | 用于治疗稳定期慢性阻塞性肺疾病的中药组合物 | |
| CN108686157B (zh) | 一种防治瘀血阻滞型乳癖的中药组合物、其制备方法及药物制剂 | |
| CN104857121A (zh) | 一种治疗高血脂症的药物组合物及其应用 | |
| CN117180387B (zh) | 一种治疗风痰阻络型周围性面瘫的组合物及其制备方法 | |
| CN116983359B (zh) | 治疗糖尿病合并冠心病稳定型心绞痛的药物组合物 | |
| CN115887601B (zh) | 一种用于痔疮的组合物及其制备方法 | |
| CN117462642B (zh) | 一种治疗腹泻的中药组合物及其制备方法和用途 | |
| CN112618425A (zh) | 一种多效修润养发精华液的制备方法 | |
| CN111658748A (zh) | 用于治疗痛经的组合物、口服制剂及应用 | |
| CN108992655A (zh) | 一种消炎祛肿的中药及其制备方法 | |
| CN106266625B (zh) | 一种治疗肾功能不全的中药组合物及其制备方法 | |
| CN104906352A (zh) | 一种治疗虚火上炎型小儿口疮的中药药液及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |